Celebrating Our Commitment to Positive Change: The 2023 B Impact Report
AstraGin® Shows Significant Improvement in Arginine Absorption for Cardiovascular Wellness in Latest Study
AstraGin® Demonstrates Improvements in Gut Health in Human Clinical Trial
PRESS RELEASE: NuLiv Science Awarded Natural Product Number (NPN) from Health Canada to Expand Skin Health Ingredient, Astrion™, into Canadian Market
PRESS RELEASE: Zylaria™ Exhibits Strong Neuroprotective Activity by Improving GABA Release in New Study
PRESS RELEASE: NuLiv Science Proudly Announces B-Corp Status
New human clinical study on InnoSlim® supports adiponectin and AMPK activation
NuLiv Science Receives Positive Clinical Study Results On Its 90-Day Toxicity Study For ASTRAGIN®
NuLiv Science Awarded Natural Product Number (NPN) From Health Canada To Expand Nutraceutical Ingredient, ASTRAGIN®, Into Canadian Market